Full Text View
Tabular View
No Study Results Posted
Related Studies
Predictors for Response to Dose-dense Docetaxel and Epirubicin Breast Cancer (MEDOBREC)
This study is currently recruiting participants.
Verified May 2012 by University of Bergen
Study NCT00496795   Information provided by University of Bergen

First Received on July 3, 2007.   Last Updated on May 16, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial